Estradiol Hemihydrate M20 EP/USP Powder, packaged in a) 1.5 kg and b) 2.5 kg fiber drums, Rx only...

FDA Drug Recall #D-1433-2012 — Class II — May 8, 2012

Recall Summary

Recall Number D-1433-2012
Classification Class II — Moderate risk
Date Initiated May 8, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Bayer HealthCare Pharmaceuticals Inc.
Location Wayne, NJ
Product Type Drugs
Quantity 112.295 kg

Product Description

Estradiol Hemihydrate M20 EP/USP Powder, packaged in a) 1.5 kg and b) 2.5 kg fiber drums, Rx only, Art. No. 165811, Bayer Pharma AG, D-13342 Berlin.

Reason for Recall

Cross Contamination w/Other Products: This active pharmaceutical ingredient is being recalled due to cross contamination with another product.

Distribution Pattern

Kansas and California.

Lot / Code Information

Lot Number: 81202450, Exp 06/15/16

Other Recalls from Bayer HealthCare Pharmaceuticals Inc.

Recall # Classification Product Date
D-0145-2024 Class I VITRAKVI (larotractenib) oral solution, 20mg/mL... Nov 6, 2023
D-0253-2022 Class I Tinactin (Tolnaftate 1%) POWDER SPRAY NET WT 13... Oct 1, 2021
D-0251-2022 Class I Tinactin (Tolnaftate 1%) LIQUID SPRAY NET WT150... Oct 1, 2021
D-0242-2022 Class II Tinactin (Tolnaftate 1%) DEODORANT POWDER SPRAY... Oct 1, 2021
D-0247-2022 Class I LOTRIMIN AF, (Miconazole nitrate 2%), Jock Itch... Oct 1, 2021

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.